PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsCommentDifficult decisions faced by women with a BRCA gene mutation

BioNews

Difficult decisions faced by women with a BRCA gene mutation

Published 28 May 2013 posted in Comment and appears in BioNews 706

Author

Chris Jacobs

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

The news about Angelina Jolie opting for a double mastectomy to reduce her risk of breast cancer has undoubtedly raised concerns among women with a family history of the disease. Whilst this news has certainly raised awareness of hereditary cancer, there are two key points that it is important to emphasize...

The news about
Angelina Jolie opting for a double mastectomy to reduce her risk of breast
cancer has undoubtedly raised concerns among women with a family history of the
disease. Whilst this news has certainly
raised awareness of hereditary cancer, there are two key points that it is
important to emphasize. Firstly, the majority of breast and ovarian cancer is not
due to an inherited cause, and secondly, double mastectomy may not be the right
choice for every woman who has a genetic predisposition to the disease.

One in eight
women will develop breast cancer at some point in their lifetime, mostly after
the age of 50. Ovarian cancer is less common, with approximately one woman in
70 developing the disease, again usually after the menopause. Many women will
therefore have a family history of the disease and most of these women will not
be at risk of hereditary cancer.

Most cancer
occurs as we get older because our cells acquire faults (mutations) in their
DNA over time. These mutations can affect genes that regulate cell growth. Most
of these, so-called somatic mutations, are repaired by highly evolved
biological mechanisms. The BRCA1 and BRCA2 genes encode proteins that play an
essential role in DNA repair, and so help to prevent cancer developing.
Although our cells acquire mutations through ageing, most of us also carry
inherited mutations we were born with. These 'constitutional mutations' can
affect how our bodies develop and function. Constitutional mutations in BRCA1 or BRCA2 can affect DNA repair and cause an increased risk of
developing cancer. However, only around one in 500 people from most populations
carry a mutation in either BRCA1 or BRCA2, making them a rare cause of
breast cancer.

A person who
inherits a BRCA1 or BRCA2 mutation will be more likely to
develop breast and ovarian cancer. However, cancer is not inevitable. The lifetime risks associated with mutations
in these genes are high (up to approximately 80 percent risk of breast cancer
and 50 percent risk of ovarian cancer by age 70). However, the
risk to the individual woman depends on a number of factors, such as age,
ethnicity, family history and the gene involved. Men who have a BRCA1/2
mutation may also be at increased risk of cancer and, like women, can pass a
mutation onto their children.

A woman with a
strong family history of breast and ovarian cancer will be offered genetic
counselling
via a Regional Genetics Centre. Genetic counselling is provided by
doctors and genetic counsellors with specialist training in clinical genetics
and aims to help the individual and family to understand and adjust to the genetic
condition
and to choose a course of action to manage the risks.

In some families,
genetic testing may be offered. For genetic testing to be useful in clarifying
a person’s risk of developing cancer, a gene mutation must first be identified
in a relative who has had the relevant cancer (a diagnostic test). If such a
mutation is found, a predictive genetic test for that mutation can then be
offered to other members of the family. Deciding whether or not to take a
genetic test involves careful consideration of the possible outcomes and
implications of testing for the individual and family.

For women who
have inherited a BRCA1 or BRCA2 gene mutation there are complex
and difficult decisions to make about how to manage the cancer risks. Breast screening is offered from age 30 and
involves a combination of mammograms and MRI, magnetic resonance imaging scans, which are more sensitive
than mammograms at detecting early cancer in young women. At present there is
no ovarian screening available on the NHS, but women with a mutation may opt to
have their ovaries and fallopian tubes removed once they have completed their
families and when they reach their early 40s.

Double
mastectomy and reconstruction is an option that women may consider. This
surgery reduces the risk of breast cancer by 90 percent, bringing the risk down
to a level similar to that of women in the general population. However, the
psychological, social and physical impact of risk-reducing surgery needs
careful thought. For some women, the decision to have surgery is
straightforward; for others it is extremely complex. Involvement of the
multidisciplinary team and the provision of support, both during decision-making
and after surgery, are vital.

It is important to remember that most
breast and ovarian cancer is not inherited. However, the revelation made by
Angelina Jolie raises awareness of the difficult choices faced by women with a
strong family history of the disease. It also highlights the importance of providing
genetic counselling, information and support to women who are making tough
decisions about genetic testing and risk management.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
6 May 2016 • 3 minutes read

More young women with cancer having BRCA testing

by Jonathan Bestwick

More than 95 percent of younger women diagnosed with early-onset breast cancer are opting for genetic testing, a study has found...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
27 March 2015 • 3 minutes read

Angelina Jolie has ovaries and fallopian tubes removed to reduce BRCA risk

by Sophie McLachlan

In an article in the New York Times, Angelina Jolie has revealed her decision to have her ovaries and fallopian tubes removed, in her on-going battle to reduce her risk of cancer...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
31 March 2014 • 4 minutes read

Harnessing the 'Angelina effect': Improving care for people with a family history of breast cancer in the UK

by Dr Caroline Dalton

As we learn more, and as technologies develop, there are continuing challenges for the NHS to meet in providing the best possible care for people at risk of familial breast cancer...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
28 March 2014 • 3 minutes read

BRCA1 cancer study suggests alternative to major surgery

by Dr Sarah West

BRCA1 mutations put carriers at high risk of cancer by failing to protect cells against the effects of high levels of oestrogen hormone found in breast and ovary tissue, researchers have established...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
4 October 2013 • 2 minutes read

The Jolie effect: breast cancer gene testing increases, but so do surgery requests

by Ruth Retassie

A London clinic has reported an increase in the number of requests for BRCA genetic testing and preventative mastectomies since Angelina Jolie's announcement last May that she had undergone a double mastectomy....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
5 April 2013 • 2 minutes read

Over 80 genetic regions linked to breast, prostate or ovarian cancer

by Siobhan Chan

The largest ever study into cancer genes has identified more than 80 genetic markers for breast, prostate and ovarian cancer....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
15 March 2013 • 3 minutes read

Breast cancer blood test tracks treatment response

by Dr Nikki Davis

A blood test is being developed that could help doctors monitor how breast cancer tumours respond to therapy...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
21 June 2010 • 1 minute read

MP's wife fights gene fault with breast op

by Dr Vivienne Raper

The wife of Labour leadership contender Andy Burnham has had a double masectomy after a genetic test showed she had a raised risk of breast cancer...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Response to Ben Saer

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.
easyfundraising
amazon

This month in BioNews

  • Recent
27 June 2022 • 4 minutes read

Thirty years of PET: our 'Fertility, Genomics and Embryo Research' report

27 June 2022 • 5 minutes read

Children's rights and donor conception: What next?

20 June 2022 • 4 minutes read

The problems with lifting donor anonymity earlier

20 June 2022 • 6 minutes read

An adaptive act: How should human fertilisation and embryology legislation respond to scientific and technological change?

13 June 2022 • 1 minute read

A new look for BioNews

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856